Effect of a serine protease inhibitor on the progression of chronic renal failure

American Journal of Physiology - Renal Physiology

Volumn 303, Issue 8, 2012, Pages

  Hayata, Manabu ^a   Kakizoe, Yutaka ^a   Uchimura, Kohei ^a   Morinaga, Jun ^a   Yamazoe, Rika ^a   Mizumoto, Teruhiko ^a   Onoue, Tomoaki ^a   Ueda, Miki ^a   Shiraishi, Naoki ^a   Adachi, Masataka ^a   Miyoshi, Taku ^a   Sakai, Yoshiki ^b   Tomita, Kimio ^a   Kitamura, Kenichiro ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

^b ONO PHARMACEUTICAL CO   (Japan)

Author keywords

Fibrosis; Inflammation; Oxidative stress; Serine protease inhibitor

Indexed keywords

CAMOSTAT MESILATE; COLLAGEN TYPE 1; COLLAGEN TYPE 3; COLLAGEN TYPE 4; CREATININE; MESSENGER RNA; NEPHRIN; SYNAPTOPODIN; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE COURSE; DRUG MECHANISM; GLOMERULOSCLEROSIS; HISTOPATHOLOGY; KIDNEY FIBROSIS; KIDNEY HYPERTROPHY; MACROPHAGE; MALE; NEPHRECTOMY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEINURIA; RAT;

EID: 84867711563     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00706.2011     Document Type: Article

References (50)

1. Abate A, Schroder H. Protease inhibitors protect macrophages from lipopolysaccharide-induced cytotoxicity: possible role for NF-kappaB. Life Sci 62: 1081-1088, 1998.
2. Abbate M, Zoja C, Corna D, Capitanio M, Bertani T, Remuzzi G. In progressive nephropathies, overload of tubular cells with filtered proteins translates glomerular permeability dysfunction into cellular signals of interstitial inflammation. J Am Soc Nephrol 9: 1213-1224, 1998.
3. Amaya Y, Yamazaki K, Sato M, Noda K, Nishino T, Nishino T. Proteolytic conversion of xanthine dehydrogenase from the NAD-dependent type to the O2-dependent type. Amino acid sequence of rat liver xanthine dehydrogenase and identification of the cleavage sites of the enzyme protein during irreversible conversion by trypsin. J Biol Chem 265: 14170-14175, 1990.
4. An WS, Kim HJ, Cho KH, Vaziri ND. Omega-3 fatty acid supplementation attenuates oxidative stress, inflammation, and tubulointerstitial fi-brosis in the remnant kidney. Am J Physiol Renal Physiol 297: F895-F903, 2009.
5. Aoshiba K, Yasuda K, Yasui S, Tamaoki J, Nagai A. Serine proteases increase oxidative stress in lung cells. Am J Physiol Lung Cell Mol Physiol 281: L556-L564, 2001.
6. Asami T, Tomisawa S, Uchiyama M. Effect of oral camostat mesilate on hematuria and/or proteinuria in children. Pediatr Nephrol 19: 313-316, 2004.
7. Asokananthan N, Graham PT, Fink J, Knight DA, Bakker AJ, McWilliam AS, Thompson PJ, Stewart GA. Activation of protease-activated receptor (PAR)-1, PAR-2, and PAR-4 stimulates IL-6, IL-8, and prostaglandin E2 release from human respiratory epithelial cells. J Immunol 168: 3577-3585, 2002.
8. Bautista-Garcia P, Sanchez-Lozada LG, Cristobal-Garcia M, Tapia E, Soto V, vila-Casado MC, Marquez-Velasco R, Bojalil R, Franco M, Herrera-Acosta J. Chronic inhibition of NOS-2 ameliorates renal injury, as well as COX-2 and TGF-beta 1 overexpression in 5/6 nephrectomized rats. Nephrol Dial Transplant 21: 3074-3081, 2006.
9. Bobadilla NA, Tack I, Tapia E, Sanchez-Lozada LG, Santamaria J, Jimenez F, Striker LJ, Striker GE, Herrera-Acosta J. Pentosan poly-sulfate prevents glomerular hypertension and structural injury despite persisting hypertension in 5/6 nephrectomy rats. J Am Soc Nephrol 12: 2080-2087, 2001.
10. Brenner BM. Hemodynamically mediated glomerular injury and the progressive nature of kidney disease. Kidney Int 23: 647-655, 1983.
11. Chen CL, Wang SD, Zeng ZY, Lin KJ, Kao ST, Tani T, Yu CK, Wang JY. Serine protease inhibitors nafamostat mesilate and gabexate mesilate attenuate allergen-induced airway inflammation and eosinophilia in a murine model of asthma. J Allergy Clin Immunol 118: 105-112, 2006.
12. Cunningham MA, Rondeau E, Chen X, Coughlin SR, Holdsworth SR, Tipping PG. Protease-activated receptor 1 mediates thrombin-dependent, cell-mediated renal inflammation in crescentic glomerulonephritis. J Exp Med 191: 455-462, 2000.
13. Davies M, Martin J, Thomas GJ, Lovett DH. Proteinases and glomer-ular matrix turnover. Kidney Int 41: 671-678, 1992.
14. Fujihara CK, Malheiros DM, Zatz R, Noronha IL. Mycophenolate mofetil attenuates renal injury in the rat remnant kidney. Kidney Int 54: 1510-1519, 1998.
15. Gibo J, Ito T, Kawabe K, Hisano T, Inoue M, Fujimori N, Oono T, Arita Y, Nawata H. Camostat mesilate attenuates pancreatic fibrosis via inhibition of monocytes and pancreatic stellate cells activity. Lab Invest 85: 75-89, 2005.
16. Grandaliano G, Monno R, Ranieri E, Gesualdo L, Schena FP, Mar-tino C, Ursi M. Regenerative and proinflammatory effects of thrombin on human proximal tubular cells. J Am Soc Nephrol 11: 1016-1025, 2000.
17. Gui Y, Loutzenhiser R, Hollenberg MD. Bidirectional regulation of renal hemodynamics by activation of PAR1 and PAR2 in isolated perfused rat kidney. Am J Physiol Renal Physiol 285: F95-F104, 2003.
18. Harada N, Okajima K, Kushimoto S. Gabexate mesilate, a synthetic protease inhibitor, reduces ischemia/reperfusion injury of rat liver by inhibiting leukocyte activation. Crit Care Med 27: 1958-1964, 1999.
19. Haraguchi M, Border WA, Huang Y, Noble NA. t-PA promotes glomerular plasmin generation and matrix degradation in experimental glomerulonephritis. Kidney Int 59: 2146-2155, 2001.
20. Hostetter TH, Olson JL, Rennke HG, Venkatachalam MA, Brenner BM. Hyperfiltration in remnant nephrons: a potentially adverse response to renal ablation. Am J Physiol Renal Fluid Electrolyte Physiol 241: F85-F93, 1981.
21. Ikeda Y, Ito H, Hashimoto K. Effect of camostat mesilate on urinary protein excretion in three patients with advanced diabetic nephropathy. J Diabetes Complications 13: 56-58, 1999.
22. Inagi R, Miyata T, Maeda K, Sugiyama S, Miyama A, Nakashima I. FUT-175 as a potent inhibitor of C5/C3 convertase activity for production of C5a and C3a. Immunol Lett 27: 49-52, 1991.
23. Inagi R, Miyata T, Oda O, Maeda K, Inoue K. Evaluation of the proteolytic activity of factor D accumulated as an active serine protease in patients with chronic renal failure. Nephron 66: 285-290, 1994.
24. Johnson RJ, Couser WG, Alpers CE, Vissers M, Schulze M, Kle-banoff SJ. The human neutrophil serine proteinases, elastase and cathep-sin G, can mediate glomerular injury in vivo. J Exp Med 168: 1169-1174, 1988.
25. Kakizoe Y, Kitamura K, Ko T, Wakida N, Maekawa A, Miyoshi T, Shiraishi N, Adachi M, Zhang Z, Masilamani S, Tomita K. Aberrant ENaC activation in Dahl salt-sensitive rats. J Hypertens 27: 1679-1689, 2009.
26. Kang DH, Nakagawa T, Feng L, Watanabe S, Han L, Mazzali M, Truong L, Harris R, Johnson RJ. A role for uric acid in the progression of renal disease. J Am Soc Nephrol 13: 2888-2897, 2002.
27. Kawachi H, Koike H, Kurihara H, Yaoita E, Orikasa M, Shia MA, Sakai T, Yamamoto T, Salant DJ, Shimizu F. Cloning of rat nephrin: expression in developing glomeruli and in proteinuric states. Kidney Int 57: 1949-1961, 2000.
28. Kitagawa S, Takaku F, Sakamoto S. Evidence that proteases are involved in superoxide production by human polymorphonuclear leukocytes and monocytes. J Clin Invest 65: 74-81, 1980.
29. Lane PH, Steffes MW, Mauer SM. Estimation of glomerular volume: a comparison of four methods. Kidney Int 41: 1085-1089, 1992.
30. Maekawa A, Kakizoe Y, Miyoshi T, Wakida N, Ko T, Shiraishi N, Adachi M, Tomita K, Kitamura K. Camostat mesilate inhibits prostasin activity and reduces blood pressure and renal injury in salt-sensitive hypertension. J Hypertens 27: 181-189, 2009.
31. Mainardi CL, Dixit SN, Kang AH. Degradation of type IV (basement membrane) collagen by a proteinase isolated from human polymorphonu-clear leukocyte granules. J Biol Chem 255: 5435-5441, 1980.
32. Masilamani S, Kim GH, Mitchell C, Wade JB, Knepper MA. Aldo-sterone-mediated regulation of ENaC alpha, beta, and gamma subunit proteins in rat kidney. J Clin Invest 104: R19-R23, 1999.
33. Matsubara M, Taguma Y, Kurosawa K, Hotta O, Suzuki K, Futaki G. Effect of camostat mesilate on heavy proteinuria in various nephropathies. Clin Nephrol 32: 119-123, 1989.
34. Onbe T, Makino H, Kumagai I, Haramoto T, Murakami K, Ota Z. Effect of proteinase inhibitor camostat mesilate on nephrotic syndrome with diabetic nephropathy. J Diabetes Complications 5: 167-168, 1991.
35. Papi A, Contoli M, Gasparini P, Bristot L, Edwards MR, Chicca M, Leis M, Ciaccia A, Caramori G, Johnston SL, Pinamonti S. Role of xanthine oxidase activation and reduced glutathione depletion in rhinovi-rus induction of inflammation in respiratory epithelial cells. J Biol Chem 283: 28595-28606, 2008.
36. Quiroz Y, Ferrebuz A, Romero F, Vaziri ND, Rodriguez-Iturbe B. Melatonin ameliorates oxidative stress, inflammation, proteinuria, and progression of renal damage in rats with renal mass reduction. Am J Physiol Renal Physiol 294: F336-F344, 2008.
37. Raij L, Azar S, Keane W. Mesangial immune injury, hypertension, and progressive glomerular damage in Dahl rats. Kidney Int 26: 137-143, 1984.
38. Remuzzi G, Benigni A, Remuzzi A. Mechanisms of progression and regression of renal lesions of chronic nephropathies and diabetes. J Clin Invest 116: 288-296, 2006.
39. Rodriguez-Iturbe B, Pons H, Herrera-Acosta J, Johnson RJ. Role of immunocompetent cells in nonimmune renal diseases. Kidney Int 59: 1626-1640, 2001.
40. Romero F, Rodriguez-Iturbe B, Parra G, Gonzalez L, Herrera-Acosta J, Tapia E. Mycophenolate mofetil prevents the progressive renal failure induced by 5/6 renal ablation in rats. Kidney Int 55: 945-955, 1999.
41. Scandiuzzi L, Beghdadi W, Daugas E, Abrink M, Tiwari N, Brochetta C, Claver J, Arouche N, Zang X, Pretolani M, Monteiro RC, Pejler G, Blank U. Mouse mast cell protease-4 deteriorates renal function by contributing to inflammation and fibrosis in immune complex-mediated glomerulonephritis. J Immunol 185: 624-633, 2010.
42. Shah SV. Role of reactive oxygen metabolites in experimental glomerular disease. Kidney Int 35: 1093-1106, 1989.
43. Shibata S, Nagase M, Yoshida S, Kawachi H, Fujita T. Podocyte as the target for aldosterone: roles of oxidative stress and Sgk1. Hypertension 49: 355-364, 2007.
44. Shimamura T, Morrison AB. A progressive glomerulosclerosis occurring in partial five-sixths nephrectomized rats. Am J Pathol 79: 95-106, 1975.
45. Speer CP, Pabst MJ, Hedegaard HB, Rest RF, Johnston RB Jr. Enhanced release of oxygen metabolites by monocyte-derived macro-phages exposed to proteolytic enzymes: activity of neutrophil elastase and cathepsin G. J Immunol 133: 2151-2156, 1984.
46. Tamura Y, Hirado M, Okamura K, Minato Y, Fujii S. Synthetic inhibitors of trypsin, plasmin, kallikrein, thrombin, C1r-, and C1 esterase. Biochim Biophys Acta 484: 417-422, 1977.
47. Thuillier R, Favreau F, Celhay O, Macchi L, Milin S, Hauet T. Thrombin inhibition during kidney ischemia-reperfusion reduces chronic graft inflammation and tubular atrophy. Transplantation 90: 612-621, 2010.
48. Uchiba M, Okajima K, Kaun C, Binder BR, Wojta J. Gabexate mesilate, a synthetic anticoagulant, inhibits the expression of endothe-lial leukocyte adhesion molecules in vitro. Crit Care Med 31: 1147-1153, 2003.
49. Vaziri ND, Dicus M, Ho ND, Boroujerdi-Rad L, Sindhu RK. Oxidative stress and dysregulation of superoxide dismutase and NADPH oxidase in renal insufficiency. Kidney Int 63: 179-185, 2003.
50. Witko-Sarsat V, Friedlander M, Capeillere-Blandin C, Nguyen-Khoa T, Nguyen AT, Zingraff J, Jungers P, Scamps-Latscha B. Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int 49: 1304-1313, 1996.